Growth is driven by unmet needs in LDL-cholesterol reduction, personalized therapy strategies, and expanding access to biologic lipid-lowering agents and novel lipid management platforms globally. https://www.datamintelligence.com/research-report/hypercholesterolemia-treatment-market